Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A randomised, double-blind study comparing the efficacy and safety of 145 mg fenofibrate, 10 mg Ezetimibe and their combination in patients with type IIb dyslipidemia and features of the metabolic syndrome

Next Previous
Trial Profile

A randomised, double-blind study comparing the efficacy and safety of 145 mg fenofibrate, 10 mg Ezetimibe and their combination in patients with type IIb dyslipidemia and features of the metabolic syndrome

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 12 Jul 2011

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Fenofibrate (Primary) ; Ezetimibe
  • Indications Dyslipidaemias; Hyperlipidaemia; Lipid metabolism disorders; Metabolic syndrome
  • Focus Therapeutic Use
  • Sponsors Laboratorios Fournier

Most Recent Events

  • 12 Jul 2011 New source identified and integrated (European Clinical Trials Database record, EudraCT2004-002408-13).
  • 20 Apr 2010 Actual patient numbers amended from (186) to (181) as reported by ClinicalTrials.gov.
  • 11 May 2007 Status change from in progress to completed.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top